» Authors » Brett Tornwall

Brett Tornwall

Explore the profile of Brett Tornwall including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 124
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Murphy A, Brzezinski J, Renfro L, Tornwall B, Malek M, Benedetti D, et al.
Int J Cancer . 2024 Jul; 155(10):1824-1831. PMID: 38973574
The objective of this study is to report the long-term timing and patterns of relapse for children enrolled in Children's Oncology Group AREN0534, a multicenter phase III clinical trial conducted...
2.
Romao R, Aldrink J, Renfro L, Mullen E, Murphy A, Brzezinski J, et al.
Pediatr Blood Cancer . 2024 Apr; 71(7):e30981. PMID: 38637871
Introduction: The purpose of this study is to examine the outcomes in children with anaplastic bilateral Wilms tumor (BWT) from study AREN0534 in order to define potential prognostic factors and...
3.
Murphy A, Cheng C, Williams J, Shaw T, Pinto E, Dieseldorff-Jones K, et al.
Nat Commun . 2023 Dec; 14(1):8006. PMID: 38110397
Developing synchronous bilateral Wilms tumor suggests an underlying (epi)genetic predisposition. Here, we evaluate this predisposition in 68 patients using whole exome or genome sequencing (n = 85 tumors from 61...
4.
Benedetti D, Varela C, Renfro L, Tornwall B, Dix D, Ehrlich P, et al.
Cancer . 2023 Nov; 130(6):947-961. PMID: 37933882
Background: Patients with stage IV favorable histology Wilms tumor (FHWT) with extrapulmonary metastases (EPM) constitute a small subset of patients with FHWT. Because of their rarity and heterogeneity, optimal FHWT...
5.
Murphy A, Cheng C, Williams J, Shaw T, Pinto E, Dieseldorff-Jones K, et al.
Res Sq . 2023 Mar; PMID: 36993649
This study comprehensively evaluated the landscape of genetic and epigenetic events that predispose to synchronous bilateral Wilms tumor (BWT). We performed whole exome or whole genome sequencing, total-strand RNA-seq, and...
6.
Madanat-Harjuoja L, Renfro L, Klega K, Tornwall B, Thorner A, Nag A, et al.
J Clin Oncol . 2022 May; 40(26):3047-3056. PMID: 35580298
Purpose: The utility of circulating tumor DNA (ctDNA) analyses has not been established in the risk stratification of Wilms tumor (WT). We evaluated the detection of ctDNA and selected risk...
7.
Chintagumpala M, Perlman E, Tornwall B, Chi Y, Kim Y, Hoffer F, et al.
Cancer . 2022 Apr; 128(13):2493-2503. PMID: 35383900
Background: An objective of the Children's Oncology Group AREN0534 Study was to improve the survival of patients with bilateral Wilms tumors (BWT) by using preoperative chemotherapy of limited duration and...
8.
Ehrlich P, Tornwall B, Chintagumpala M, Chi Y, Hoffer F, Perlman E, et al.
Ann Surg Oncol . 2022 Jan; 29(5):3262-3263. PMID: 35076770
No abstract available.
9.
Ehrlich P, Tornwall B, Chintagumpala M, Chi Y, Hoffer F, Perlman E, et al.
Ann Surg Oncol . 2022 Jan; 29(5):3252-3261. PMID: 35072864
Introduction: Diffuse hyperplastic perilobar nephroblastomatosis (DHPLN) represents a unique category of nephroblastomatosis. Treatment has ranged from observation to multiple regimens of chemotherapy. Wilms tumors (WTs) develop in 100% of untreated...
10.
Geller J, Cost N, Chi Y, Tornwall B, Cajaiba M, Perlman E, et al.
Cancer . 2020 Sep; 126(23):5156-5164. PMID: 32926409
Background: To the authors' knowledge, AREN0321 is the first prospective clinical study of pediatric and adolescent renal cell carcinoma (RCC). Goals of the study included establishing epidemiological, treatment, and outcome...